About Index Trending news
Analyze
Pricing
Atlas Genetics

Atlas Genetics

Work at Atlas Genetics? Add yourself to this profile

Atlas Genetics

Atlas is an innovative, UK-based point-of-care diagnostics company. The Atlas io™ platform will revolutionise near-patient testing.
Edit Profile
More info

Elsewhere

Contributors to this profile

Companies in the same industry

AltheaDx AltheaDx MorphoSys AG MorphoSys AG LipoScience LipoScience Cancer Genetics Inc. Cancer Genetics Inc. BioFire Diagnostics BioFire Diagnostics QuantaLife QuantaLife Sedia Biosciences Sedia Biosciences Diagnostic Hybrids Diagnostic Hybrids Beacon Biomedical Beacon Biomedical NanoCellect Biomedical, Inc. NanoCellect Biomedical, Inc.

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 4
Add info
27 Jan 2017
$35,000,000
Venture capital (Series D)
Novartis Venture Fund, South West Ventures Fund, BB Biotech Ventures, +5
Added by

Atlas Genetics raises $35m Series D, Theresa May's Industrial Strategy & more in the Week in Tech

Tech City News
29 Jan 2015
$20,000,000
Venture capital (Series C)
Novartis Venture Fund, South West Ventures Fund, BB Biotech Ventures, +3

Atlas Genetics Completes $20m Series C Fundraising

sys-con
+2
28 Apr 2014
£16,900,000
Venture capital (Series B)
Johnson & Johnson Development Corporation, Novartis Venture Fund, Life Sciences Partners, +3
18 Jul 2011
£16,900,000
Venture capital (Series B)
Johnson & Johnson Development Corporation, Novartis Venture Fund, Life Sciences Partners, +2